 Source: Connect world Shutterstock.com Genetic-sequence product specialist Illumina NASDAQ: ILMN lit up business headlines on Thursday evening after the company secured a legal victory in an antitrust suit. Although ILMN stock bounced higher this morning, shares are now slipping about 2 in the Friday afternoon session. 